Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 3, 1998, Pages 410-420

  Abdelaziz, Muntasir M ^a,b   Devalia, Jagdish L ^b   Khair, Omer A ^a   Bayram, Hasan ^b   Prior, Andrew J ^a   Davies, Robert J ^b  

^a London Chest Hospital ^*

^b LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

Allergic rhinitis; Cytokines; Eosinophils; Epithelial permeability; Fexofenadine; Nasal epithelial cells

Indexed keywords

FEXOFENADINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; RANTES; TERFENADINE;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ADHESION; CHEMOTAXIS; CYTOKINE RELEASE; ENDOTHELIUM CELL; EOSINOPHILIA; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL;

EID: 0031920720     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70256-8     Document Type: Article

References (61)

1. Holgate ST, Roche WR, Church MK. The role of the eosinophil in asthma. Am Rev Respir Dis 1991;143:566-77.
2. Kay AB, Corrigan CJ. Eosinophils and neutrophils. Br Med Bull 1991;48:51-64.
3. Corrigan CJ, Kay AB. The role of inflammatory cells in the pathogenesis of asthma and chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;143:1165-8.
4. Venge P, Dahl R. Are blood eosinophil number and activity important for the development of the late asthmatic reaction after allergen challenge? Eur Respir J 1989;2:430S-4S.
5. Devalia JL, Sapsford R, Rusznak C, Davies R. The effect of activated eosinophils on cultured human nasal epithelial cell activity and the influence of nedocromil sodium in vitro. Am J Respir Cell Mol Biol 1992;7:270-7.
6. Pelikan Z, Pelikan-Filipek M. Cytological changes in the nasal secretion during late nasal response. J Allergy Clin Immunol 1989;63:1068-79.
7. Pipkorn U, Karlsson G, Enerback L. The cellular response of the human nasal mucosa to natural allergen response. J Allergy Clin Immunol 1988;63:1046-54.
8. Malmberg H. Symptoms of chronic and allergic rhinitis and occurrence of nasal secretion granulocytes in university students, school children and infants. Allergy 1979;34:389-4.
9. Denburg JA, Jordana M, Gibson P, Hargreave F, Gauldie J, Dolovich J. Cellular and molecular basis of allergic airways inflammation. In: Johanssen SGO, editor. Pharmacia Allergy Research Foundation. Award Book 1990. Upssala: AW Grafiska; 1990. p. 15-22.
10. Cromwell O, Hamid Q, Corrigan CJ, Barkans J, Meng Q, Collins PD, et al. Expression and generation of interleukin-8, IL-6, granulocyte-macrophage-colony stimulating factor by bronchial epithelial cells and enhancement by interleukin-1β and tumour necrosis factor-a. Immunology 1992;77:330-7.
11. Devalia JL, Campbell AM, Sapsford R, Rusnak C, Quint D, Godard P, et al. The effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 1993;9:271-8.
12. Wang JH, Devalia JL, Xia C, Sapsford R, Davies R. Expression of RANTES in human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol 1996;9:271-8.
13. Mattoli S, Miante S, Calabro F, Mazzetti M, Allegra L. Human bronchial epithelial cells exposed to isocyanates potentiate the activation and proliferation of T cells induced by antigen receptor triggering through the release of IL-1 and IL-6. In: Johanssen SGO, editor. Pharmacia Allergy Research Foundation. Award Book 1990. Upssala: AW Graflska; 1990. p. 25-35.
14. Levine SJ. Bronchial epithelial cell-cytokine interactions in airway inflammation. J Invest Med 1995;43:241-9.
15. Abdelaziz MM, Devalia JL, Khair OA, Calderon M, Sapsford R, Davies R. The effect of conditioned medium from cultured human bronchial epithelial cells on eosinophil and neutrophil chemotaxis and adherence, in vitro. Am J Respir Cell Mol Biol 1995;13:728-37.
16. Barnes PJ, Adock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993;14:436-41.
17. Sousa AR, Poston RN, Lane SJ, Nakhosteen JA, Lee TH. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am Rev Respir Dis 1993;147:1557-61.
18. Trigg O, Manolitsas ND, Wang JH, Calderon MA, McAulay A, Jordan SE, et al. Placebo-controlled immunopathological study of four months inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994;150:17-22.
19. White MV, Slater JE, Kaliner MA. Histamine and asthma. Am Rev Respir Dis 1987;135:1165-76.
20. Pipkorn U. Mediators and nasal allergy. Clin Exp Allergy 1989;26:585-9.
21. Trigg CJ, Davies R. Local antihistamine. Clin Exp Allergy 1996;26:1108-11.
22. Taytard A, Beaumont D, Pujet JC, Sapene M, Lewis PJ. Treatment of bronchial asthma with terfenadine: a randomised controlled trial. Br J Clin Pharmacol 1987;24:743-6.
23. Nabe M, Agrawal DK, Sarmiento EU, Townley RG. Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils. Clin Exp Allergy 1989;19:515-20.
24. Akagi M, Mio M, Miyoshi K, Tasaka K. Antiallergic effects of terfenaine on immediate type hypersensitivity reactions. Immunopharmacol Immunotoxicol 1987;9:257-79.
25. De Vos C, Joseph M, Leprevost C, Vorng H, Tomassini M, Capron M, et al. Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine. Int Arch Allergy Appl Immunol 1989;88:212-5.
26. Kyan-Aung U, Hallsworth M, Haskard D, De Vos C, Lee T. The effects of cetirizine on the adhesion of human eosinophils and neutrophils to cultured human umbilical vein endothelial cells. J Allergy Clin Immunol 1992;90:270-2.
27. Lippert C, Ling J, Brown P, Burmaster S, Eller M, Cheng L, et al. Mass balance and pharmacokinetics of fexofenadine HCI in healthy, male volunteers. Pharm Res 1995;12(suppl 1):S390.
28. Calderön MA, Devalia JL, Prior AJ, Sapsford R, Davies R. A comparison of cytokine release from epithelial cells cultured from nasal biopsy specimens of atopic patients with and without rhinitis, and nonatopic subjects without rhinitis. J Allergy Clin Immunol 1997;99:65-76.
29. Devalia JL, Sapsford R, Wells C, Richman P, Davies R. Culture and comparison of human bronchial and nasal epithelial cells in vitro. Respir Med 1990;84:303-12.
30. Devalia JL, Godfrey RWA, Sapsford R, Severs NJ, Jeffery PK, Davies R. No effect of histamine on human bronchial epithelial cell permeability and tight junctional integrity in vitro. Eur Respir J 1994;7:1958-65.
31. Kloprogge E, de Leeuw AJ, de Monchy JGR, Kauffman HF. Hypodense eosinophilic granulocytes in normal individuals and patients with asthma: generation of hypodense cell populations in vitro. J Allergy Clin Immunol 1989;83:393-400.
32. Kimura I, Moritani Y, Tanizaki Y. Basophils in bronchial asthma with reference to reagin-type allergy. Clin Allergy 1973;3:195-202.
33. Cates KL, Ray CE, Quie PG. Modified Boyden chamber method of measuring polymorphonuclear leukocyte chemotaxis. In: Gallin JI, Quie PG, editors. Leukocyte chemotaxis: methods, physiology, and clinical implications. New York: Raven Press; 1978. p. 67-71.
34. Andrews PC, Krinsky NI. The reactive cleavage of the myeloperoxidase in half, producing enzymatically active hemi-myeloperoxidase. J Biol Chem 1981;256:4211-8.
35. Lippert U, Kruger-Krasagakes S, Moller A, Kiessling U, Czarnetzki BM. Pharmacological modulation of IL-6 and IL-8 secretion by H-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol 1995;4:272-6.
36. Vignola AM, Crampette L, Mondain M, Sauvere G, Czarlewski W, Bousquet J, et al. Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells. Allergy 1995;50:200-3.
37. Greiff L, Persson CGA, Svensson C, Enander I, Anderson M. Loratadine reduces allergen-induced mucosal output of a2-macr°globulin and tryptase in allergic rhinitis. J Allergy Clin Immunol 1995;96:97-103.
38. Ciprandi G, Pronzato C, Passalacqua G, Ricca V, Bagnasco M, Grogen J, et al. Topical azelastine reduces eosinophil and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity. J Allergy Clin Immunol 1996;96:1088-96.
39. Ciprandi G, Pronzato C, Ricca V, Varese P, Del Giacco OS, Canonica GW. Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy. Clin Exp Allergy 1995;25:871-8.
40. Wang D, Clement P, Smitz J. Effect of HI and H2 antagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season. Acta Otolaryngol 1996;116:91-6.
41. Alvarado-Valdes CA, Blomgren J, Weiler D, Gleich GJ, Reed CE, Field EA, et al. The effect of fluticasone propionate aqueous nasal spray on eosinophils and cytokines in nasal secretions of patients with ragweed allergic rhinitis. Clin Ther 1997;19:273-81.
42. Fadel R, Herpin-Richard N, Rihoux JP, Henocq E. Inhibitory effect of ceterizine 2HC1 on eosinophil migration in vivo. Clin Allergy 1987;17:373-9.
43. Michel L, De Vos C, Rihoux JP, Burtin C, Benveniste J, Dubertret L. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. J Allergy Clin Immunol 1988;82:101-9.
44. Charlesworth EN, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Effect of ceterizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 1989;83:905-12.
45. Mctavish D, Goa KL, Ferrill M. Terfenadine: an updated review of its pharmacological properties and therapeutic efficacy. Drugs 1990;39:552-74.
46. Rafferty P, Holgate ST. Terfenadine is a potent and selective histamine H; receptor antagonist in asthmatic airways. Am Rev Respir Dis 1987;135:181-4.
47. Rafferty P, Beasley R, Holgate ST. The contribution of histamine to immediate bronchoconstriction provoked by allergen and adenosine 5'-monophosphate in atopic asthma. Am Rev Respir Dis 1987;136:369-73.
48. Patel KR. Terfenadine in exercise induced asthma. BMJ 1984;288:1496-7.
49. Pratt CM, Ruberg S, Morganroth J, McNutt B, Woodward J, Harris S, et al. Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability. Am Heart J 1996;131:472-80.
50. Pratt C, Mason J, Russell T, Ahlbrandt R. Effect of fexofenadine HC1 on corrected QT interval (QTc). Allergy 1997;52(suppl 37):67.
51. Stern M, Bloom M. Fexofenadine HCI versus cetirizine as a once daily treatment for seasonal allergic rhinitis. British Society for Allergy and Clinical Immunology Book of Abstracts 1996;10.
52. Leurs R, Smit MJ, Timmerman H. Molecular pharmacological aspects of histamine receptors. Pharmacol Ther 1995;66:413-63.
53. Seifert R, Hoer A, Schwaner I, Buschauer A. Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation. Mol Pharmacol 1992;42:235-41.
54. Masuo M, Shimada T, Kitazawa T. Mechanism of inhibitory effects of azelastine on smooth muscle contraction. J Pharmacol Exp Ther 1992;26:1300-8.
55. Hazama H, Nakajima T, Hisada T, Hamada E, Omata M, Kurachi Y. Effects of azelastine on membrane currents in tracheal smooth muscle cells isolated from the guinea pig. Eur J Pharmacol 1994;259:143-50.
56. Miadonna A, Milazzo N, Lorini M, Marchesi E, Tedeschi A. Inhibitory effect of the H; antagonist loratadine on histamine release from human basophils. Int Arch Allergy Immunol 1994;105:12-7.
57. Burgoyne RD, Cheek TR. Locating intracellular calcium stores. Trends Biochem Sci 1991;16:319-20.
58. Berridge MJ, Irvine RF. Inositol phosphates and cell signaling. Nature 1989;341:197-205.
59. Kennerly D, Duffy P. Activation mechanisms of mast cells and basophils. In: Holgate ST, Church MK, editors. Allergy. London: Gower Medical Publishing; 1993. p. 4.1-4.14.
60. Karin M. The AP-1 complex and its role in transcriptional control by protein kinase C. In: Cohen P, Foulkes G, editors. Molecular aspects of cellular regulation. Vol 6. Amsterdam: Elsevier/North Holland Biomedical Press; 1990. p. 143-61.
61. Muegge K, Durum SK. From cell code to gene code: cytokines and transcription factors. Research review. The New Biologist 1989;!: 239-45.